Investigating diabetes that develops after acute pancreatitis
Indiana University clinical Center for acute pancreatitis and diabetes clinical research network
This study is looking at how diabetes can develop after a serious pancreas problem called acute pancreatitis, and it's for adults who have had this condition; the goal is to learn more about what causes this type of diabetes so we can find better ways to help people manage it.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-10898861 on NIH RePORTER |
What this research studies
This research focuses on pancreatogenic diabetes, also known as type 3c diabetes, which can develop as a complication of acute pancreatitis. The study aims to understand the various metabolic and immune-related factors that contribute to this condition by observing adults who have experienced acute pancreatitis. Participants will undergo extensive evaluations to identify the natural history of diabetes following pancreatitis, including the presence of autoantibodies and glucose tolerance issues. The research team at Indiana University is collaborating with experts in diabetes and pancreatic health to gather comprehensive data that could lead to better management strategies for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who have experienced acute pancreatitis and may be at risk for developing type 3c diabetes.
Not a fit: Patients who have not had acute pancreatitis or do not have diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients who develop diabetes after acute pancreatitis.
How similar studies have performed: Previous research has indicated that understanding the relationship between pancreatitis and diabetes can lead to significant advancements in treatment, suggesting that this approach has potential for success.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Fogel, Evan L — Indiana University Indianapolis
- Study coordinator: Fogel, Evan L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.